[go: up one dir, main page]

DE602005027127D1 - Nachweis eines therapeutischen antikörpers in einem versuchstier - Google Patents

Nachweis eines therapeutischen antikörpers in einem versuchstier

Info

Publication number
DE602005027127D1
DE602005027127D1 DE602005027127T DE602005027127T DE602005027127D1 DE 602005027127 D1 DE602005027127 D1 DE 602005027127D1 DE 602005027127 T DE602005027127 T DE 602005027127T DE 602005027127 T DE602005027127 T DE 602005027127T DE 602005027127 D1 DE602005027127 D1 DE 602005027127D1
Authority
DE
Germany
Prior art keywords
therapeutic antibody
sample
therapeutic
antibody
experimental animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005027127T
Other languages
English (en)
Inventor
Helmut Lenz
Kay-Gunnar Stubenrauch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34927934&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602005027127(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE602005027127D1 publication Critical patent/DE602005027127D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602005027127T 2004-12-23 2005-12-22 Nachweis eines therapeutischen antikörpers in einem versuchstier Expired - Lifetime DE602005027127D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04030545 2004-12-23
PCT/EP2005/013849 WO2006066912A2 (en) 2004-12-23 2005-12-22 Detection of a therapeutic antibody in an experimental animal

Publications (1)

Publication Number Publication Date
DE602005027127D1 true DE602005027127D1 (de) 2011-05-05

Family

ID=34927934

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005027127T Expired - Lifetime DE602005027127D1 (de) 2004-12-23 2005-12-22 Nachweis eines therapeutischen antikörpers in einem versuchstier

Country Status (15)

Country Link
US (1) US7955806B2 (de)
EP (2) EP1853921B2 (de)
JP (2) JP4664377B2 (de)
KR (1) KR100950635B1 (de)
CN (1) CN101088014B (de)
AT (1) ATE503187T1 (de)
AU (2) AU2005318407B2 (de)
BR (1) BRPI0519354B8 (de)
CA (1) CA2589054C (de)
DE (1) DE602005027127D1 (de)
ES (1) ES2360369T5 (de)
MX (1) MX2007006895A (de)
RU (1) RU2393483C2 (de)
SG (1) SG164389A1 (de)
WO (1) WO2006066912A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101506659B (zh) * 2006-09-12 2012-12-12 弗·哈夫曼-拉罗切有限公司 抗药物抗体测定法
CA2662416C (en) * 2006-09-12 2014-12-16 F. Hoffmann-La Roche Ag Anti-drug antibody assay
EP2344884B1 (de) * 2008-10-07 2013-07-31 Gyros Patent Ab Semisequentieller test für den nachweis eines analyten in einer probe
MX2011004923A (es) * 2008-11-10 2011-05-30 Novartis Ag Anticuerpos para peptidos de igf-1/e humanos modificados.
US9957331B2 (en) * 2009-10-19 2018-05-01 Hoffmann-La Roche Inc. Non-cross-reactive anti IgG antibodies
EP2606071B1 (de) * 2010-08-17 2019-12-18 F.Hoffmann-La Roche Ag Humaner anti-igg1-antikörper
MX352118B (es) 2012-03-08 2017-11-09 Hoffmann La Roche Metodo de inmunoanalisis cromatografico multiplexado para la caracterizacion de inmunocomplejos circulantes.
EP3540438A1 (de) 2012-08-17 2019-09-18 MorphoSys AG Komplex-spezifische antikörper und antikörperfragmente und deren verwendung
EP2986990B1 (de) * 2013-03-20 2018-08-15 F.Hoffmann-La Roche Ag Spezifische detektion von rattenantikörpern in mausserum
CN108350450B (zh) * 2015-11-09 2022-07-05 国立大学法人京都工艺纤维大学 人血清来源的IgG多克隆抗体的分离剂、以及使用其的人血清来源的IgG多克隆抗体的分离方法
CN107703310B (zh) * 2017-10-11 2019-08-30 潍坊医学院附属医院 一种针对老鼠免疫抗体的实验操作系统
US11913945B2 (en) * 2020-01-02 2024-02-27 Hoffmann-La Roche Inc. Method for determining the amount of a therapeutic antibody in the brain

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2095818B (en) 1981-03-27 1985-10-02 Exxon Research Engineering Co Staged adsorption/resorption heat pump
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4870003A (en) * 1987-06-15 1989-09-26 Coulter Corporation Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans
US4816067A (en) * 1988-06-20 1989-03-28 Gte Products Corporation Process for producing fine spherical particles
DE69233254T2 (de) 1991-06-14 2004-09-16 Genentech, Inc., South San Francisco Humanisierter Heregulin Antikörper
WO1993021319A1 (en) 1992-04-08 1993-10-28 Cetus Oncology Corporation HUMANIZED C-erbB-2 SPECIFIC ANTIBODIES
US5736137A (en) * 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
JP2000516594A (ja) 1996-07-26 2000-12-12 スミスクライン・ビーチャム・コーポレイション 免疫細胞介在全身性疾患の改良された治療法
US6525174B1 (en) * 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
US6413783B1 (en) * 1997-09-18 2002-07-02 Meso Scale Technologies, Llc Assay sonication apparatus and methodology
JP2000304750A (ja) * 1999-04-16 2000-11-02 Fuji Photo Film Co Ltd 発光標識イムノアッセイ及びその分析要素
IT1315254B1 (it) * 1999-11-05 2003-02-03 Diesse Diagnostica Senese Spa Metodo per la determinazione qualitativa e quantitativa di anticorpiumani di classe igc.
AUPR617901A0 (en) 2001-07-06 2001-08-02 Pacmab Pty Ltd Method for treating multiple myeloma
EP2131198B1 (de) 2001-09-20 2013-03-27 Board of Regents, The University of Texas System Messung der zirkulierenden therapeutischen Antikörper-, Antigen- und Antigen-/Antikörperkomplexe unter Verwendung enzymgekoppelter Immunadsorptionstests
JP4636225B2 (ja) 2002-11-30 2011-02-23 司甫 横山 検査試薬キット

Also Published As

Publication number Publication date
SG164389A1 (en) 2010-09-29
RU2007128103A (ru) 2009-01-27
ES2360369T5 (es) 2021-12-13
AU2005318407A1 (en) 2006-06-29
KR100950635B1 (ko) 2010-04-01
AU2010200299A1 (en) 2010-02-18
RU2393483C2 (ru) 2010-06-27
ATE503187T1 (de) 2011-04-15
EP1853921B2 (de) 2021-07-21
CA2589054A1 (en) 2006-06-29
KR20070086642A (ko) 2007-08-27
AU2005318407B2 (en) 2009-11-05
JP2011039072A (ja) 2011-02-24
CN101088014B (zh) 2012-10-03
CA2589054C (en) 2010-11-02
EP1853921B1 (de) 2011-03-23
JP4664377B2 (ja) 2011-04-06
MX2007006895A (es) 2007-06-26
JP2008525766A (ja) 2008-07-17
US20080102474A1 (en) 2008-05-01
ES2360369T3 (es) 2011-06-03
EP1853921A2 (de) 2007-11-14
EP2237041A1 (de) 2010-10-06
BRPI0519354B1 (pt) 2020-06-09
BRPI0519354B8 (pt) 2021-07-27
WO2006066912A3 (en) 2006-08-10
CN101088014A (zh) 2007-12-12
US7955806B2 (en) 2011-06-07
WO2006066912A9 (en) 2007-02-22
BRPI0519354A2 (pt) 2009-01-20
WO2006066912A2 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
TW200741203A (en) Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody
DE602005013225D1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
WO2006089027A3 (en) Lateral flow test kit and method for detecting an analyte
ATE411525T1 (de) Nachweis einer histonmodifikation in zellfreien nukleosomen
ATE452343T1 (de) Verbesserte vitamin-d-messung
DE602005027127D1 (de) Nachweis eines therapeutischen antikörpers in einem versuchstier
NZ609824A (en) Immunochromatography devices, methods and kits
ATE466108T1 (de) Optoelektronisches detektionssystem
MX369610B (es) Metodos, dispositivos y sistemas para analisis de muestras.
WO2005103698A3 (en) Methods and antibodies for nitrofuran detection
DE602006011756D1 (de) Komplexformierungs- und -trennungsverfahren
WO2005080985A3 (en) Methods and compositions for detecting and treating autoimmune diseases
WO2011037827A3 (en) Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
WO2005019831A3 (en) Methods for reducing complexity of a sample using small epitope antibodies
ATE408837T1 (de) Verfahren zum nachweis von infektionen mit mykobakterien
WO2007147141A3 (en) Methods for detecting molecular complexes
WO2008067008A3 (en) A method for the quantitative evaluation of sex hormones in a serum sample
EP2012116A4 (de) Verfahren und vorrichtung zur individuellen unterscheidung
WO2007024735A3 (en) Method and antibodies for detecting nitrofuran
WO2004084841A3 (en) Novel anti-feline albumin antibodies and methods of detecting early renal disease
WO2002077645A3 (en) Method for the measurement of soluble analytes
WO2008067007A3 (en) A method for quantitative measurement of thyroid homrones and related antibodies in a serum sample
MX2015013364A (es) Deteccion especifica de anticuerpos de rata en suero de raton.
ATE520985T1 (de) Verfahren zur bestimmung von antigen und antikörper gegen das antigen
WO2008036474A3 (en) A method to detect tumor markers and diagnosis of undifferenciated tumors